• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Narrative review of the safety and efficacy of marijuana for the treatment of commonly state-approved medical and psychiatric disorders.关于大麻用于治疗常见国家批准的医学和精神疾病的安全性和有效性的叙述性综述。
Addict Sci Clin Pract. 2015 Apr 21;10:10. doi: 10.1186/s13722-015-0032-7.
2
Medical marijuana patient counseling points for health care professionals based on trends in the medical uses, efficacy, and adverse effects of cannabis-based pharmaceutical drugs.基于大麻类药物的医学用途、疗效及不良反应趋势,为医疗保健专业人员提供的医用大麻患者咨询要点。
Res Social Adm Pharm. 2016 Jul-Aug;12(4):638-54. doi: 10.1016/j.sapharm.2015.09.002. Epub 2015 Sep 16.
3
Clinical Data for the Use of Cannabis-Based Treatments: A Comprehensive Review of the Literature.临床使用大麻类药物治疗的数据:文献综述
Ann Pharmacother. 2020 Nov;54(11):1109-1143. doi: 10.1177/1060028020930189. Epub 2020 Jun 2.
4
Medical use of cannabis products: Lessons to be learned from Israel and Canada.大麻产品的医学用途:从以色列和加拿大汲取的经验教训。
Schmerz. 2016 Feb;30(1):3-13. doi: 10.1007/s00482-015-0083-4.
5
Medical marijuana: Showdown at the cannabis corral.医用大麻:大麻领域的对决。
Nature. 2015 Sep 24;525(7570):S15-7. doi: 10.1038/525S15a.
6
Self-reported cannabis use characteristics, patterns and helpfulness among medical cannabis users.医用大麻使用者自我报告的大麻使用特征、模式及效用。
Am J Drug Alcohol Abuse. 2014 Jan;40(1):23-30. doi: 10.3109/00952990.2013.821477. Epub 2013 Nov 8.
7
The Changing Drug Culture: Medical and Recreational Marijuana.不断变化的毒品文化:医用大麻与消遣用大麻
FP Essent. 2016 Feb;441:11-7.
8
Medical Marijuana for Treatment of Chronic Pain and Other Medical and Psychiatric Problems: A Clinical Review.医用大麻治疗慢性疼痛及其他医学和精神疾病:临床综述。
JAMA. 2015;313(24):2474-83. doi: 10.1001/jama.2015.6199.
9
Is cannabis treatment for anxiety, mood, and related disorders ready for prime time?大麻治疗焦虑、情绪和相关障碍是否已经成熟?
Depress Anxiety. 2017 Nov;34(11):1006-1017. doi: 10.1002/da.22664. Epub 2017 Jun 21.
10
Medical marijuana: legal considerations.医用大麻:法律考量
STEP Perspect. 1999 Summer;99(2):5.

引用本文的文献

1
Blinded by the Mind: Exploring the Hidden Psychiatric Burden in Glaucoma Patients.被心智蒙蔽:探索青光眼患者隐藏的精神负担
Biomedicines. 2025 Jan 7;13(1):116. doi: 10.3390/biomedicines13010116.
2
Botulinum toxin in the rehabilitation of painful syndromes: multiperspective literature analysis, lexical analysis and systematic review of randomized controlled trials.肉毒杆菌毒素在疼痛综合征康复中的应用:多视角文献分析、词汇分析及随机对照试验的系统评价
Eur J Transl Myol. 2024 May 20;34(2):12509. doi: 10.4081/ejtm.2024.12509.
3
"We want what's best for patients." nurse leaders' attitudes about medical cannabis: A qualitative study.“我们希望为患者谋求最佳利益。”护士领导者对医用大麻的态度:一项定性研究。
Int J Nurs Stud Adv. 2022 Jan 30;4:100065. doi: 10.1016/j.ijnsa.2022.100065. eCollection 2022 Dec.
4
Pharmacokinetics of delta-9-tetrahydrocannabinol following acute cannabis smoke exposure in mice; effects of sex, age, and strain.小鼠急性吸入大麻烟雾后Δ⁹-四氢大麻酚的药代动力学;性别、年龄和品系的影响
Front Pharmacol. 2023 Aug 28;14:1227220. doi: 10.3389/fphar.2023.1227220. eCollection 2023.
5
Biosynthesis of Phytocannabinoids and Structural Insights: A Review.植物大麻素的生物合成与结构洞察:综述
Metabolites. 2023 Mar 17;13(3):442. doi: 10.3390/metabo13030442.
6
Examining the role of cannabinoids on osteoporosis: a review.研究大麻素在骨质疏松症中的作用:综述
Arch Osteoporos. 2022 Nov 19;17(1):146. doi: 10.1007/s11657-022-01190-x.
7
A bibliometric analysis of the cannabis and cannabinoid research literature.大麻与大麻素研究文献的文献计量分析
J Cannabis Res. 2022 May 25;4(1):25. doi: 10.1186/s42238-022-00133-0.
8
Slovenian Pet Owners' Experience, Attitudes, and Predictors Regarding Cannabinoid Use in Dogs and Cats.斯洛文尼亚宠物主人关于在犬猫中使用大麻素的经历、态度及预测因素
Front Vet Sci. 2022 Jan 5;8:796673. doi: 10.3389/fvets.2021.796673. eCollection 2021.
9
Green Hope: Perspectives on Cannabis from People who Use Opioids.绿色希望:阿片类药物使用者对大麻的看法。
Sociol Inq. 2021 Aug;91(3):668-695. doi: 10.1111/soin.12359. Epub 2020 Feb 13.
10
Generalized Anxiety Disorder 7-Item (GAD-7) Scores in Medically Authorized Cannabis Patients-Ontario and Alberta, Canada.加拿大安大略省和艾伯塔省经医学授权使用大麻的患者的广泛性焦虑障碍7项量表(GAD-7)评分
Can J Psychiatry. 2022 Jun;67(6):470-480. doi: 10.1177/07067437211043393. Epub 2021 Sep 14.

本文引用的文献

1
The efficacy of nabilone, a synthetic cannabinoid, in the treatment of PTSD-associated nightmares: A preliminary randomized, double-blind, placebo-controlled cross-over design study.合成大麻素那必隆治疗创伤后应激障碍相关噩梦的疗效:一项初步随机双盲安慰剂对照交叉设计研究
Psychoneuroendocrinology. 2015 Jan;51:585-8. doi: 10.1016/j.psyneuen.2014.11.002. Epub 2014 Nov 8.
2
Preliminary, open-label, pilot study of add-on oral Δ9-tetrahydrocannabinol in chronic post-traumatic stress disorder.口服Δ9-四氢大麻酚辅助治疗慢性创伤后应激障碍的初步开放标签试验研究。
Clin Drug Investig. 2014 Aug;34(8):587-91. doi: 10.1007/s40261-014-0212-3.
3
Adverse health effects of marijuana use.使用大麻对健康的不良影响。
N Engl J Med. 2014 Jun 5;370(23):2219-27. doi: 10.1056/NEJMra1402309.
4
Interactions between disordered sleep, post-traumatic stress disorder, and substance use disorders.睡眠障碍、创伤后应激障碍和物质使用障碍之间的相互作用。
Int Rev Psychiatry. 2014 Apr;26(2):237-47. doi: 10.3109/09540261.2014.901300.
5
Effects of cannabis on cognition in patients with MS: a psychometric and MRI study.大麻对多发性硬化症患者认知功能的影响:一项心理测量和核磁共振成像研究。
Neurology. 2014 May 27;82(21):1879-87. doi: 10.1212/WNL.0000000000000446. Epub 2014 Apr 30.
6
Systematic review: efficacy and safety of medical marijuana in selected neurologic disorders [RETIRED]: report of the Guideline Development Subcommittee of the American Academy of Neurology.系统评价:医用大麻在特定神经系统疾病中的疗效与安全性[已停用]:美国神经病学学会指南制定小组委员会报告
Neurology. 2014 Apr 29;82(17):1556-63. doi: 10.1212/WNL.0000000000000363.
7
Cannabinoids for treatment of Alzheimer's disease: moving toward the clinic.大麻素用于治疗阿尔茨海默病:迈向临床应用
Front Pharmacol. 2014 Mar 5;5:37. doi: 10.3389/fphar.2014.00037. eCollection 2014.
8
Cannabinoids for epilepsy.用于癫痫的大麻素。
Cochrane Database Syst Rev. 2014 Mar 5;2014(3):CD009270. doi: 10.1002/14651858.CD009270.pub3.
9
Nabiximols (THC/CBD oromucosal spray, Sativex®) in clinical practice--results of a multicenter, non-interventional study (MOVE 2) in patients with multiple sclerosis spasticity.纳布西莫尔(四氢大麻酚/大麻二酚口腔黏膜喷雾剂,商品名:萨替维克斯)在临床实践中的应用——一项针对多发性硬化症痉挛患者的多中心、非干预性研究(MOVE 2)的结果
Eur Neurol. 2014;71(5-6):271-9. doi: 10.1159/000357427. Epub 2014 Feb 12.
10
Cannabinoid hyperemesis syndrome.大麻素呕吐综合征
Hosp Pharm. 2013 Sep;48(8):650-5. doi: 10.1310/hpj4808-650.

关于大麻用于治疗常见国家批准的医学和精神疾病的安全性和有效性的叙述性综述。

Narrative review of the safety and efficacy of marijuana for the treatment of commonly state-approved medical and psychiatric disorders.

作者信息

Belendiuk Katherine A, Baldini Lisa L, Bonn-Miller Marcel O

机构信息

Institute of Human Development, University of California, 1121 Tolman Hall #1690, Berkeley, CA, 94720, USA.

Palo Alto University, 1791 Arastradero Road, Palo Alto, CA, 94304, USA.

出版信息

Addict Sci Clin Pract. 2015 Apr 21;10:10. doi: 10.1186/s13722-015-0032-7.

DOI:10.1186/s13722-015-0032-7
PMID:25896576
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4636852/
Abstract

The present investigation aimed to provide an objective narrative review of the existing literature pertaining to the benefits and harms of marijuana use for the treatment of the most common medical and psychological conditions for which it has been allowed at the state level. Common medical conditions for which marijuana is allowed (i.e., those conditions shared by at least 80 percent of medical marijuana states) were identified as: Alzheimer's disease, amyotrophic lateral sclerosis, cachexia/wasting syndrome, cancer, Crohn's disease, epilepsy and seizures, glaucoma, hepatitis C virus, human immunodeficiency virus/acquired immunodeficiency syndrome, multiple sclerosis and muscle spasticity, severe and chronic pain, and severe nausea. Post-traumatic stress disorder was also included in the review, as it is the sole psychological disorder for which medical marijuana has been allowed. Studies for this narrative review were included based on a literature search in PsycINFO, MEDLINE, and Google Scholar. Findings indicate that, for the majority of these conditions, there is insufficient evidence to support the recommendation of medical marijuana at this time. A significant amount of rigorous research is needed to definitively ascertain the potential implications of marijuana for these conditions. It is important for such work to not only examine the effects of smoked marijuana preparations, but also to compare its safety, tolerability, and efficacy in relation to existing pharmacological treatments.

摘要

本调查旨在对现有文献进行客观的叙述性综述,这些文献涉及在州一级允许使用大麻治疗最常见的医学和心理疾病的益处和危害。大麻被允许用于治疗的常见医学疾病(即至少80%的医用大麻州都认可的疾病)包括:阿尔茨海默病、肌萎缩侧索硬化症、恶病质/消瘦综合征、癌症、克罗恩病、癫痫和发作、青光眼、丙型肝炎病毒、人类免疫缺陷病毒/获得性免疫缺陷综合征、多发性硬化症和肌肉痉挛、严重慢性疼痛以及严重恶心。创伤后应激障碍也被纳入综述,因为它是唯一一种允许使用医用大麻治疗的心理疾病。本次叙述性综述的研究是基于在PsycINFO、MEDLINE和谷歌学术上的文献检索而纳入的。研究结果表明,对于这些疾病中的大多数,目前没有足够的证据支持推荐使用医用大麻。需要进行大量严格的研究来明确确定大麻对这些疾病的潜在影响。此类研究不仅要考察吸食大麻制剂的效果,还应比较其与现有药物治疗相比的安全性、耐受性和疗效,这一点很重要。